speb/financial-data huggingface dataset:
NEOGEN.NS cash_flow (annual, 2024-03-31) — Depreciation: 225900000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 228700000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 228700000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 225900000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 0.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 25540299.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Diluted EPS: 13.96
NEOGEN.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 356500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 0.00
NEOGEN.NS income_statement (annual, 2024-03-31) — EBIT: 905500000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — EBITDA: 1134200000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — End Cash Position: 125000000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Financial Assets: 0.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 2365300000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 767400000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -3319200000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -73100000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 127300000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 11500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2816900000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 6675500000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Gross Profit: 2667500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 2400000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Interest Expense: 377800000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 377800000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Interest Income: 74100000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 74100000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -420600000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 73100000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Inventory: 3824400000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 11538200000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -2155800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 4800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 4500000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 2466500000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 666200000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1384800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 134500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 1242300000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1376800000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 666200000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -352900000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 4500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 90700000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2703000000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 35200000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 2466500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Net Debt: 3813000000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -10400000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Net Income: 356500000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 356500000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 356500000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 356500000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 356500000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 527700000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 356500000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -100000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Net Interest Income: -346500000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 0.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 313300000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 313300000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -346500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Net PPE: 6034100000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -3027600000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 7591400000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Non Current Accrued Expenses: 0.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 0.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 237300000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 90700000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 721900000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1134200000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Normalized Income: 356500000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: -291500000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Operating Income: 871900000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Operating Revenue: 6708300000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 26381674.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 100000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 100000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 7339100000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 11500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 36900000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 347500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -300000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 100000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 600000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 601000000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Payable: 994800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Properties: 660600000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 732900000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 30500000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Payables: 2475400000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 13100000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 307100000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Pretax Income: 527700000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 0.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -100000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -3027600000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 368100000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 4040800000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 228700000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 38400000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 38400000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -352900000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Research And Development: 34900000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 0.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 1981500000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Sale Of Business: 35200000.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 0.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 0.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 177300000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 304600000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Share Issued: 26381674.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Special Income Charges: 0.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 7602900000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 7591400000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Tax Provision: 171200000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.32
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 0.00
NEOGEN.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -97500000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Total Assets: 14614000000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 8845200000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Total Debt: 4089200000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 7602900000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Total Expenses: 5836400000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 7011100000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 6777400000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1741400000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 42800000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 34600000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 0.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 1400000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Work In Process: 2652000000.00
NEOGEN.NS balance_sheet (annual, 2024-03-31) — Working Capital: 2566900000.00
NEOGEN.NS income_statement (annual, 2024-03-31) — Write Off: 0.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 1501700000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2222600000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 122300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 310100000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 263800000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 62600000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1098700000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 263800000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 7771900000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 1308100000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 7729900000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 53100000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 3610400000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 3663500000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Deferred Taxes Liabilities: 39900000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 5677300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 15300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 10200000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 6495800000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 4010100000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 12804600000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 122300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 257000000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1422300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1679300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 105300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 4970100000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 6495800000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 7761700000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 246300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 26381674.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 392200000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 158800000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 7508100000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1145100000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 5187700000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 6300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1036100000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Payables: 1501700000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 26381674.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 7771900000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 7761700000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 0.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 15503300000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 9194200000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 5342800000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 7771900000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 7731400000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 7773400000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 2054100000.00
NEOGEN.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 2052600000.00
NEOGEN.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
NEOGEN.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
NEOGEN.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
NEOGEN.NS income_statement (annual, 2025-03-31) — +Operating Expense: 2459700000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 657000000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — +Total Revenue: 7775600000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2028200000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 2631900000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2631900000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2002200000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2002200000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -698800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -698800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 5219800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 5219800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -26900000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -26900000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Amortization: 2500000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 2500000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 18900000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 18900000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 26386364.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 26483516.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Basic EPS: 13.20
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.91
NEOGEN.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 125000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 550100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 550100000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -3177100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 307000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 307000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 263800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 263800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 49600000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 49600000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 353500000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 353500000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -52800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 49600000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 49600000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -1201700000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 107800000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -440500000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Change In Payable: 1132400000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 1049400000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 647400000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -75400000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Common Stock: 263800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 263800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 7894000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 7894000000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: 0.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1561900000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1561900000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 4230600000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1075000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Current Assets: 9998300000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 9998300000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 68900000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 68900000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Current Debt: 3959400000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 3959400000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 4028300000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4028300000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 7334000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 7334000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 42100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 42100000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Depreciation: 277900000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 277900000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 277900000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 67600000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 277900000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 67600000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 0.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 0.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 26386364.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 26483516.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Diluted EPS: 13.20
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.91
NEOGEN.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 348300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 24100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 0.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 0.00
NEOGEN.NS income_statement (annual, 2025-03-31) — EBIT: 986600000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — EBIT: 161800000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — EBITDA: 1264500000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — EBITDA: 229400000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — End Cash Position: 49600000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Financial Assets: 0.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets: 0.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 1130700000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 167000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 167000000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -1217300000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
NEOGEN.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 128600000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 9400000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 9400000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2029100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2029100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 6290000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6290000000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Gross Profit: 3545000000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 953200000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 0.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 0.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Interest Expense: 485000000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 125000000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 485000000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 125000000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Interest Income: 15700000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 15700000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -478400000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 10900000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Inventory: 3091300000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 3091300000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 13554400000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 13554400000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -3165900000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 18900000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 18900000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 4500000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 4500000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 2443100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1404100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1404100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 238100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 238100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 1701000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1701000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1939100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1939100000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 2443100000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -718000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 4500000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 4500000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 111000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 111000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 1883600000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1883600000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Net Debt: 5610800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 5610800000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 18200000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Net Income: 348300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Net Income: 24100000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 348300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 24100000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 348300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 24100000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 348300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 24100000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 348300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 24100000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 501600000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 348300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 24100000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -400000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Net Interest Income: -485000000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -125000000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net Investment Properties Purchase And Sale: 0.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -4500000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 1725100000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 1725100000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -485000000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -125000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Net PPE: 5591200000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 5591200000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -3171900000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 7884600000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 7884600000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 0.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 0.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 174100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 174100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 111000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 111000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 1848300000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1848300000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1405300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 370200000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Normalized Income: 446068421.05
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 116308695.65
NEOGEN.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1959800000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Operating Income: 1085300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Operating Income: 296200000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Operating Revenue: 7775600000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2028200000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 26381674.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 26381674.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 440800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 440800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 204100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 204100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 7630100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 7630100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 9400000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 9400000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 48500000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 48500000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 628900000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: -200000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -200000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -100000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 40100000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 5900000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1533400000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 406300000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Payable: 377000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 377000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Properties: 890300000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 890300000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 4109200000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 4109200000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 303900000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 303900000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Other Special Charges: 140800000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: 140800000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Payables: 3081000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Payables: 3081000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 42100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 42100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 442100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 442100000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Pretax Income: 501600000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 36800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 8800000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -400000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -3176700000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 543200000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 543200000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 4230600000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1075000000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 277900000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 67600000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 35900000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 35900000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -718000000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: 0.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Research And Development: 11500000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 0.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 0.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 2277000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2277000000.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 0.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Sale Of Investment Properties: 0.00
NEOGEN.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 4800000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 234500000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 363100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Share Issued: 26381674.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 26381674.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Special Income Charges: -140800000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -140800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 7894000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 7894000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 7884600000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 7884600000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -43031578.95
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -48591304.35
NEOGEN.NS income_statement (annual, 2025-03-31) — Tax Provision: 153300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 12700000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.31
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.35
NEOGEN.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -123000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Total Assets: 17473100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 17473100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 9595000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 9595000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Total Debt: 5967400000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 5967400000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 7894000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 7894000000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Total Expenses: 6690300000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1732000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 9579100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 9579100000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 7474800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7474800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2245100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2245100000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 106400000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 72100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 72100000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -140800000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -140800000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -140800000.00
NEOGEN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -140800000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 1000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 1000000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Work In Process: 2332600000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 2332600000.00
NEOGEN.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2664300000.00
NEOGEN.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2664300000.00
NEOGEN.NS income_statement (annual, 2025-03-31) — Write Off: 8800000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 592500000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1867300000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 26375321.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 3.89
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1017500000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 57800000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 57800000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 26375321.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.89
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 102600000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — EBIT: 269600000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — EBITDA: 327400000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 849800000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 126700000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 126700000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Net Income: 102600000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 102600000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 102600000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 102600000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 102600000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 102600000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -126700000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -126700000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 327400000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 102600000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Operating Income: 257300000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1867300000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 11800000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 339000000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 142900000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1017500000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 57800000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 40300000.00
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
NEOGEN.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1610000000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 744600000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 2086600000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2776600000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2768700000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 349400000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 26328125.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.28
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 538100000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 263800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 113200000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 5004000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 263800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 7998000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 3352600000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1115500000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 13188900000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 116800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 4897700000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5014500000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 8367000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 43500000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 73100000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 73100000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 26328125.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.28
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 33700000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — EBIT: 246300000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — EBITDA: 319400000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 7800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 7602000000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 971100000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 194800000.00
NEOGEN.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 194800000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 4371700000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 18775000000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 349400000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 4500000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 421300000.00
NEOGEN.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 5879300000.00